Europe, Middle East, Africa (EMEA)


In Europe, an EU-wide marketing authorisation is just the beginning. Here, pricing and reimbursement processes are as diverse as the nation’s cultures themselves. At the same time, Africa and the Middle East are emerging as key frontiers in the worldwide pharma landscape. Reimbursography highlights the evolving payer environments and strategies for staying on top of the changes.